• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5072617)   Today's Articles (14)
For: Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes Obes Metab 2024;26 Suppl 4:16-27. [PMID: 38937282 DOI: 10.1111/dom.15728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/19/2024] [Revised: 06/03/2024] [Accepted: 06/03/2024] [Indexed: 06/29/2024]
Number Cited by Other Article(s)
1
Hauner H. [Implementation of guideline-based basic therapy for obesity in Germany]. Dtsch Med Wochenschr 2025;150:668-674. [PMID: 40388976 DOI: 10.1055/a-2548-1202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/21/2025]
2
Imboden MT. Access to GLP-1s: Where Do Employers Fit in? Am J Health Promot 2025;39:828-831. [PMID: 40340526 DOI: 10.1177/08901171251335507a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/10/2025]
3
Imboden MT. Knowing Well, Being Well: well-being born of understanding: Access to GLP-1s: Where Do Employers Fit in? Am J Health Promot 2025;39:828-843. [PMID: 40340527 DOI: 10.1177/08901171251335507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/10/2025]
4
Hua R, Shi M, Chow E, Yang A, Cheung YT. Genetic evidence for the effects of glucokinase activation on frailty-related outcomes: A Mendelian randomisation study. Diabetes Obes Metab 2025;27:3072-3083. [PMID: 40035195 PMCID: PMC12046474 DOI: 10.1111/dom.16312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/02/2024] [Revised: 02/19/2025] [Accepted: 02/23/2025] [Indexed: 03/05/2025]
5
Russ DW, Manickam R, Tipparaju SM. Targeting intramyocellular lipids to improve aging muscle function. Lipids Health Dis 2025;24:197. [PMID: 40450303 DOI: 10.1186/s12944-025-02622-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2025] [Accepted: 05/22/2025] [Indexed: 06/03/2025]  Open
6
Isakov V. Metabolic dysfunction-associated steatotic liver disease: A story of muscle and mass. World J Gastroenterol 2025;31:105346. [DOI: 10.3748/wjg.v31.i20.105346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/18/2025] [Revised: 04/13/2025] [Accepted: 05/09/2025] [Indexed: 05/28/2025]  Open
7
Mesinovic J, Hurst C, Leung GKW, Ryan JR, Daly RM, Scott D. Exercise and dietary recommendations to preserve musculoskeletal health during weight loss in adults with obesity: A practical guide. Rev Endocr Metab Disord 2025:10.1007/s11154-025-09968-3. [PMID: 40434574 DOI: 10.1007/s11154-025-09968-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 04/07/2025] [Indexed: 05/29/2025]
8
Culver A, Stayrook K, Comerota M, Oblak A, Burris T. Animal models for development of anti-obesity drugs in the age of GLP-1 agents. Expert Opin Drug Discov 2025:1-13. [PMID: 40380806 DOI: 10.1080/17460441.2025.2507766] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2024] [Revised: 04/09/2025] [Accepted: 05/14/2025] [Indexed: 05/19/2025]
9
Teixeira AM, Nosrani SE, Parvani M, Viola J, Mohammadi S. Sarcopenia: an Aging Perspective and Management Options. Int J Sports Med 2025. [PMID: 40199507 DOI: 10.1055/a-2577-2577] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/10/2025]
10
Bobu AM, Turliuc S, Cucu AI, Onofriescu A, Dascalu CG, Costea CF, Patrascanu E, Morosan AP, Haisan A, Filip CN, Covali R, Buzduga CM, Botnariu G, Enache IIC. Dulaglutide 1.5 mg Significantly Improves Glycemic Control and Lowers LDL-Cholesterol and Body Weight in Romanian Patients with Type 2 Diabetes. J Clin Med 2025;14:3536. [PMID: 40429530 PMCID: PMC12111957 DOI: 10.3390/jcm14103536] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2025] [Revised: 05/14/2025] [Accepted: 05/15/2025] [Indexed: 05/29/2025]  Open
11
Hoffmann C, Bendel MA. Spinal Cord Stimulation - Device Revision After Weight Loss in a Patient on Chronic Semaglutide - A Case Report. Int Med Case Rep J 2025;18:567-571. [PMID: 40395634 PMCID: PMC12091066 DOI: 10.2147/imcrj.s513630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2024] [Accepted: 05/07/2025] [Indexed: 05/22/2025]  Open
12
Gatto A, Liu K, Milan N, Wong S. The Effects of GLP-1 Agonists on Musculoskeletal Health and Orthopedic Care. Curr Rev Musculoskelet Med 2025:10.1007/s12178-025-09978-3. [PMID: 40372699 DOI: 10.1007/s12178-025-09978-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 05/02/2025] [Indexed: 05/16/2025]
13
Fang A, Frigo DE, Hahn A, Razouki Z, Hwang J, Koutroumpakis E, Lawen T, Smith M, Hamilton-Reeves J, DiGiovanni J, Higgason N, Garcia RS, Chapin BF, Pettaway C, Chery L, Troncoso P, Logothetis C, Daniel CR, Wei P, Gregg JR. GLP-1 Agonist Use Among Men with Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical Trials. Urology 2025:S0090-4295(25)00426-1. [PMID: 40348027 DOI: 10.1016/j.urology.2025.04.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2025] [Accepted: 04/29/2025] [Indexed: 05/14/2025]
14
Sun M, Wang X, Lu Z, Yang Y, Lv S, Miao M, Chen WM, Wu SY, Zhang J. Long-term delirium and survival outcomes in patients treated with GLP-1 receptor agonists versus metformin in type 2 diabetes: A population-based cohort study. Diabetes Obes Metab 2025. [PMID: 40331425 DOI: 10.1111/dom.16434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/26/2025] [Revised: 04/19/2025] [Accepted: 04/21/2025] [Indexed: 05/08/2025]
15
Romeo S, Vidal-Puig A, Husain M, Ahima R, Arca M, Bhatt DL, Diehl AM, Fontana L, Foo R, Frühbeck G, Kozlitina J, Lonn E, Pattou F, Plat J, Quaggin SE, Ridker PM, Rydén M, Segata N, Tuttle KR, Verma S, Roeters van Lennep J, Benn M, Binder CJ, Jamialahmadi O, Perkins R, Catapano AL, Tokgözoğlu L, Ray KK. Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement. Eur Heart J 2025:ehaf314. [PMID: 40331343 DOI: 10.1093/eurheartj/ehaf314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/08/2025]  Open
16
Chavez AM, Carrasco Barria R, León-Sanz M. Nutrition support whilst on glucagon-like peptide-1 based therapy. Is it necessary? Curr Opin Clin Nutr Metab Care 2025:00075197-990000000-00219. [PMID: 40401903 DOI: 10.1097/mco.0000000000001130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/23/2025]
17
Bonaca MP, Catarig AM, Houlind K, Ludvik B, Nordanstig J, Ramesh CK, Rasouli N, Sourij H, Videmark A, Verma S. Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial. Lancet 2025;405:1580-1593. [PMID: 40169145 DOI: 10.1016/s0140-6736(25)00509-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/27/2025] [Revised: 03/13/2025] [Accepted: 03/13/2025] [Indexed: 04/03/2025]
18
Stolwyk K, Lee I. Rapid progression of amyotrophic lateral sclerosis after initiation of GLP-1 agonist: a case report. Amyotroph Lateral Scler Frontotemporal Degener 2025;26:382-384. [PMID: 39772789 PMCID: PMC12005962 DOI: 10.1080/21678421.2024.2446847] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2024] [Accepted: 12/17/2024] [Indexed: 01/11/2025]
19
Memel Z, Gold SL, Pearlman M, Muratore A, Martindale R. Impact of GLP- 1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia. Curr Nutr Rep 2025;14:63. [PMID: 40289060 DOI: 10.1007/s13668-025-00649-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/26/2025] [Indexed: 04/29/2025]
20
Caturano A, Amaro A, Berra CC, Conte C. Sarcopenic obesity and weight loss-induced muscle mass loss. Curr Opin Clin Nutr Metab Care 2025:00075197-990000000-00215. [PMID: 40296814 DOI: 10.1097/mco.0000000000001131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/30/2025]
21
Bansal B, Lajeunesse-Trempe F, Keshvani N, Lavie CJ, Pandey A. Impact of Metabolic Dysfunction-associated Steatotic Liver Disease on Cardiovascular Structure, Function, and the Risk of Heart Failure. Can J Cardiol 2025:S0828-282X(25)00315-0. [PMID: 40258400 DOI: 10.1016/j.cjca.2025.04.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2025] [Revised: 04/01/2025] [Accepted: 04/10/2025] [Indexed: 04/23/2025]  Open
22
Ommi NB, Mattocks DA, Kalecký K, Bottiglieri T, Nichenametla SN. Pharmacological recapitulation of the lean phenotype induced by the lifespan-extending sulfur amino acid-restricted diet. Aging (Albany NY) 2025;17:960-981. [PMID: 40202448 PMCID: PMC12074818 DOI: 10.18632/aging.206237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2024] [Accepted: 03/20/2025] [Indexed: 04/10/2025]
23
Heymsfield SB, Ramirez S, Yang S, Thomas DM, Brown JC, Compton SLE, Schuna JM, Smith SR, Ludwig DS, Ebbeling CB. Critical analysis of dual-energy x-ray absorptiometry-measured body composition changes with voluntary weight loss. Obesity (Silver Spring) 2025;33:685-694. [PMID: 40033564 DOI: 10.1002/oby.24255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/26/2024] [Revised: 01/02/2025] [Accepted: 01/15/2025] [Indexed: 03/05/2025]
24
Forst T, De Block C, Del Prato S, Frias J, Lautenbach A, Ludvik B, Marinez M, Mathieu C, Müller TD, Schnell O. Novel pharmacotherapies for weight loss: Understanding the role of incretins to enable weight loss and improved health outcomes. Diabetes Obes Metab 2025;27 Suppl 2:48-65. [PMID: 39931897 DOI: 10.1111/dom.16247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/26/2024] [Revised: 01/25/2025] [Accepted: 01/26/2025] [Indexed: 04/17/2025]
25
Zupec J, Munger R, Scaletta A, Quinn DH. Use of glucagon-like peptide-1 receptor agonists and incretin mimetics for type 2 diabetes and obesity: A narrative review. Nutr Clin Pract 2025;40:327-349. [PMID: 39961620 DOI: 10.1002/ncp.11279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2024] [Revised: 01/15/2025] [Accepted: 01/17/2025] [Indexed: 03/06/2025]  Open
26
Weiskirchen R, Lonardo A. How 'miracle' weight-loss semaglutide promises to change medicine but can we afford the expense? Br J Pharmacol 2025;182:1651-1670. [PMID: 39947645 DOI: 10.1111/bph.70003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2024] [Revised: 12/23/2024] [Accepted: 01/23/2025] [Indexed: 03/14/2025]  Open
27
Dilaver RG, Afsar RE, Crescenzi R, Gamboa J, Ikizler TA. Effects of Dulaglutide on Ectopic Fat Deposition in Chronic Kidney Disease (CKD): A Pilot and Feasibility Study (GLIMP). MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES 2025:2025.03.19.25324266. [PMID: 40166561 PMCID: PMC11957094 DOI: 10.1101/2025.03.19.25324266] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 04/02/2025]
28
Reiss AB, Gulkarov S, Lau R, Klek SP, Srivastava A, Renna HA, De Leon J. Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss. Biomolecules 2025;15:408. [PMID: 40149944 PMCID: PMC11940170 DOI: 10.3390/biom15030408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2025] [Revised: 03/10/2025] [Accepted: 03/11/2025] [Indexed: 03/29/2025]  Open
29
Verhey JT, Austin RP, Tarabichi S, Paul B, Deckey DG, Christopher ZK, Spangehl MJ, Bingham JS. GLP-1 Agonists for Weight Loss: Do They Increase Complications in Non-diabetic Patients Undergoing Primary Total Hip Arthroplasty? J Arthroplasty 2025:S0883-5403(25)00224-4. [PMID: 40081604 DOI: 10.1016/j.arth.2025.03.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/03/2024] [Revised: 03/03/2025] [Accepted: 03/05/2025] [Indexed: 03/16/2025]  Open
30
Cortes TM, Chae K, Foy CM, Houston DK, Beavers KM. The impact of lifestyle-based weight loss in older adults with obesity on muscle and bone health: a balancing act. Obesity (Silver Spring) 2025. [PMID: 40065568 DOI: 10.1002/oby.24229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/29/2024] [Revised: 12/05/2024] [Accepted: 12/09/2024] [Indexed: 03/14/2025]
31
Wen J, Razick A, How-Volkman C, Bernstein E, Nadora D, Truong A, Razick D, Akhtar M, Karabala M, Frezza E. An exploratory analysis of glucagon-like peptide-1 (GLP-1) agonists and biosimilars: A literature review. Diabetes Obes Metab 2025;27:1113-1122. [PMID: 39654073 DOI: 10.1111/dom.16110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/22/2024] [Revised: 11/08/2024] [Accepted: 11/21/2024] [Indexed: 02/08/2025]
32
Ryan M, Megyeri S, Nuffer W, Trujillo JM. The potential role of GLP-1 receptor agonists in osteoarthritis. Pharmacotherapy 2025;45:177-186. [PMID: 39980227 DOI: 10.1002/phar.70005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2024] [Revised: 01/15/2025] [Accepted: 01/18/2025] [Indexed: 02/22/2025]
33
Stice E, Rohde P, Desjardins CD, Gee K, Shaw H, Kim S. A preliminary randomized trial of a brief dissonance-based type 2 diabetes prevention programme for adults with pre-diabetes. Diabetes Obes Metab 2025;27:1572-1579. [PMID: 39778041 PMCID: PMC11835393 DOI: 10.1111/dom.16170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/24/2024] [Revised: 12/10/2024] [Accepted: 12/19/2024] [Indexed: 01/11/2025]
34
Gigliotti L, Warshaw H, Evert A, Dawkins C, Schwartz J, Susie C, Kushner R, Subramanian S, Handu D, Rozga M. Incretin-Based Therapies and Lifestyle Interventions: The Evolving Role of Registered Dietitian Nutritionists in Obesity Care. J Acad Nutr Diet 2025;125:408-421. [PMID: 39521378 DOI: 10.1016/j.jand.2024.10.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2024] [Accepted: 10/30/2024] [Indexed: 11/16/2024]
35
Sammut MJ, Thorne BR, Melling CWJ. Skeletal muscle growth to combat diabetes and obesity: the potential role of muscle-secreted factors. Obesity (Silver Spring) 2025;33:435-451. [PMID: 39948829 PMCID: PMC11897867 DOI: 10.1002/oby.24223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/01/2024] [Revised: 11/21/2024] [Accepted: 11/22/2024] [Indexed: 03/14/2025]
36
Neagu M, Neagu A. A Decade of Progress in Ultrasound Assessments of Subcutaneous and Total Body Fat: A Scoping Review. Life (Basel) 2025;15:236. [PMID: 40003645 PMCID: PMC11856862 DOI: 10.3390/life15020236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2024] [Revised: 01/30/2025] [Accepted: 02/02/2025] [Indexed: 02/27/2025]  Open
37
Moiz A, Filion KB, Toutounchi H, Tsoukas MA, Yu OHY, Peters TM, Eisenberg MJ. Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes : A Systematic Review of Randomized Controlled Trials. Ann Intern Med 2025;178:199-217. [PMID: 39761578 DOI: 10.7326/annals-24-01590] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/19/2025]  Open
38
Ratnasingam J, Lim QH, Chan SP. Type 2 diabetes: a contemporary view from the Asian lens. Curr Opin Endocrinol Diabetes Obes 2025;32:20-25. [PMID: 39607025 DOI: 10.1097/med.0000000000000895] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2024]
39
Zushin PJH, Wu JC. Evaluating the benefits of the early use of GLP-1 receptor agonists. Lancet 2025;405:181-183. [PMID: 39547251 PMCID: PMC11921982 DOI: 10.1016/s0140-6736(24)02255-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/03/2024] [Accepted: 10/09/2024] [Indexed: 11/17/2024]
40
Jones LA, Brierley DI. GLP-1 and the Neurobiology of Eating Control: Recent Advances. Endocrinology 2025;166:bqae167. [PMID: 39813121 PMCID: PMC11745901 DOI: 10.1210/endocr/bqae167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/17/2024] [Revised: 12/09/2024] [Accepted: 12/31/2024] [Indexed: 01/18/2025]
41
Ibrahim E, Burken M, Lastra G, Manrique-Acevedo C. Prevention of cardiovascular disease in women with type 2 diabetes: the role of incretin mimetics and sodium-glucose cotransporter-2 inhibitors. Am J Physiol Cell Physiol 2025;328:C315-C322. [PMID: 39672547 PMCID: PMC11901335 DOI: 10.1152/ajpcell.00765.2024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2024] [Revised: 12/01/2024] [Accepted: 12/01/2024] [Indexed: 12/15/2024]
42
Wharton S, le Roux CW, Kosiborod MN, Platz E, Brueckmann M, Jastreboff AM, Ajaz Hussain S, Pedersen SD, Borowska L, Unseld A, Kloer IM, Kaplan LM, the SYNCHRONIZE‐1 and ‐2 trial committees and investigators. Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE™-1 and -2). Obesity (Silver Spring) 2025;33:67-77. [PMID: 39495965 PMCID: PMC11664303 DOI: 10.1002/oby.24184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/06/2024] [Revised: 10/04/2024] [Accepted: 10/07/2024] [Indexed: 11/06/2024]
43
Stoll F, Kantowski T, Laaser J, Kloiber U, Plitzko G, Mann O, Aberle J, Lautenbach A. Tackling suboptimal clinical response after metabolic bariatric surgery: Impact of tirzepatide on weight loss and body composition. Obes Res Clin Pract 2025;19:63-69. [PMID: 39952885 DOI: 10.1016/j.orcp.2025.02.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/17/2025] [Revised: 02/06/2025] [Accepted: 02/07/2025] [Indexed: 02/17/2025]
44
American Diabetes Association Professional Practice Committee, ElSayed NA, McCoy RG, Aleppo G, Balapattabi K, Beverly EA, Briggs Early K, Bruemmer D, Echouffo-Tcheugui JB, Eichorst B, Ekhlaspour L, Garg R, Hassanein M, Khunti K, Lal R, Lingvay I, Matfin G, Middelbeek RJ, Pandya N, Pekas EJ, Pilla SJ, Polsky S, Segal AR, Seley JJ, Stanton RC, Tanenbaum ML, Urbanski P, Bannuru RR. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2025. Diabetes Care 2025;48:S86-S127. [PMID: 39651983 PMCID: PMC11635047 DOI: 10.2337/dc25-s005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/14/2024]
45
American Diabetes Association Professional Practice Committee, ElSayed NA, McCoy RG, Aleppo G, Balapattabi K, Beverly EA, Briggs Early K, Bruemmer D, Echouffo-Tcheugui JB, Ekhlaspour L, Garg R, Khunti K, Kushner RF, Lal R, Lingvay I, Matfin G, Pandya N, Pekas EJ, Pilla SJ, Polsky S, Segal AR, Seley JJ, Stanton RC, Bannuru RR. 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2025. Diabetes Care 2025;48:S167-S180. [PMID: 39651976 PMCID: PMC11635032 DOI: 10.2337/dc25-s008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/14/2024]
46
Schmidt PHS, Pasqualotto E, Dos Santos HV, de Souza LSN, Dos Santos BE, Chavez MP, Ferreira ROM, Hohl A, Ronsoni MF, van de Sande-Lee S. Effects of liraglutide on body composition in people living with obesity or overweight: A systematic review. Obes Res Clin Pract 2025;19:11-18. [PMID: 39904668 DOI: 10.1016/j.orcp.2025.01.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/18/2024] [Revised: 01/19/2025] [Accepted: 01/28/2025] [Indexed: 02/06/2025]
47
Novikoff A, Grandl G, Liu X, D. Müller T. Why are we still in need for novel anti-obesity medications? THE LANCET REGIONAL HEALTH. EUROPE 2024;47:101098. [PMID: 39726721 PMCID: PMC11670685 DOI: 10.1016/j.lanepe.2024.101098] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 09/06/2024] [Revised: 10/01/2024] [Accepted: 10/02/2024] [Indexed: 12/28/2024]
48
Grandl G, Novikoff A, Liu X, Müller TD. Recent achievements and future directions of anti-obesity medications. THE LANCET REGIONAL HEALTH. EUROPE 2024;47:101100. [PMID: 39582489 PMCID: PMC11585837 DOI: 10.1016/j.lanepe.2024.101100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/07/2024] [Revised: 09/06/2024] [Accepted: 10/03/2024] [Indexed: 11/26/2024]
49
Bathina S, Lopez VF, Prado M, Ballato E, Colleluori G, Tetlay M, Villareal DT, Mediwala S, Chen R, Qualls C, Armamento‐Villareal R. Health implications of racial differences in serum growth differentiation factor levels among men with obesity. Physiol Rep 2024;12:e70124. [PMID: 39668628 PMCID: PMC11638490 DOI: 10.14814/phy2.70124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2024] [Revised: 11/04/2024] [Accepted: 11/04/2024] [Indexed: 12/14/2024]  Open
50
Pereira M, Menezes S, Franco AJ, Marcolin P, Tomera M. Role of GLP1-RA in Optimizing Weight Loss Post-Bariatric Surgery: A Systematic Review and Meta-Analysis. Obes Surg 2024;34:3888-3896. [PMID: 39215779 DOI: 10.1007/s11695-024-07486-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2024] [Revised: 08/21/2024] [Accepted: 08/23/2024] [Indexed: 09/04/2024]
PrevPage 1 of 2 12Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA